1,3-Dibromo-2,2-dimethoxypropane | CAS:22094-18-4

We serve 1,3-Dibromo-2,2-dimethoxypropane CAS:22094-18-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
1,3-Dibromo-2,2-dimethoxypropane

Chemical Name:1,3-Dibromo-2,2-dimethoxypropane
CAS.NO:22094-18-4
Synonyms:1,3-dibromoacetone dimethylacetal
Molecular Formula:C5H10Br2O2
Molecular Weight:261.94000
 
Physical and Chemical Properties:
Density:1.743
Melting point:65-68ºC
Boiling point:254.1ºC
Flash point:110.1ºC
Index of Refraction:1.499
 
Specification:
Appearance:Whit or off-white powder
Purity:≥99.0%
Moisture:≤0.5%
 
Pack:25 kg/barrel, can also be packaged according to customer requirements
Synthesis:Synthetic with acetone, methanol and bromine as raw materials
Application:Applied to the composition of a four-membered ring, polypeptide cyclization, etc.;



Contact us for information like 1,3-Dibromo-2,2-dimethoxypropane chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,3-dibromoacetone dimethylacetal physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,3-dibromoacetone dimethylacetal Use and application,1,3-dibromoacetone dimethylacetal technical grade,usp/ep/jp grade.


Related News: The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term.6-Oxo-1,6-dihydro-3-pyridazinecarboxamide manufacturer The overall competition in China’s specialty drug substance market is relatively moderate, but due to the higher technical barriers and higher entry barriers for new entrants, there will be no obvious intensified competition in the short term.4-Amino-N-Boc-L-Phenylalanine supplier The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.5'-Tosyl Adenosine vendor The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.The Breakthrough Designation for the iLet Bionic Pancreas System contemplates configurations with most insulin analogs approved for pumping as well as dasiglucagon, Zealand Pharma’s stable pumpable glucagon analog, which has a unique stability profile in a ready-to-use aqueous solution.